Bioventus (BVS) Cash from Investing Activities (2020 - 2026)
Bioventus posted quarterly Cash from Investing Activities of -$574000.0 for Q1 2026, up 30.51% year-on-year from -$439818.2 in Q1 2025, and up 1.03% on a QoQ basis from -$580000.0 in Q4 2025.
Bioventus (BVS) has 7 years of Cash from Investing Activities data on file, last reported at -$574000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 30.51% year-over-year to -$574000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.0 million (down 112.95% YoY), and the FY2025 full-year result was -$3.2 million, down 114.14% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$574000.0, up from -$580000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $24.1 million in Q4 2024 and bottomed at -$56.3 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$826000.0 (2025), against an average of -$4.1 million.
- The widest annual swing landed in 2022, when Cash from Investing Activities slumped 1864.69%; it then soared 420.75% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$3.4 million in 2022, then jumped by 420.75% to $10.9 million in 2023, then soared by 120.83% to $24.1 million in 2024, then plunged by 102.41% to -$580000.0 in 2025, then advanced by 1.03% to -$574000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$574000.0 (Q1 2026), -$580000.0 (Q4 2025), and -$473000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | -574,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -574,000.00 |
| Mar 28, 2026 | -574,000.00 |
| Dec 31, 2025 | -580,000.00 |
| Dec 31, 2025 | -580,000.00 |
| Sep 27, 2025 | -473,000.00 |
| Sep 27, 2025 | -473,000.00 |
| Jun 28, 2025 | -1.37 Mn |
| Jun 28, 2025 | -1.37 Mn |
| Mar 29, 2025 | -826,000.00 |
| Mar 29, 2025 | -826,000.00 |
| Dec 31, 2024 | 24.10 Mn |
| Dec 31, 2024 | 24.10 Mn |
| Sep 28, 2024 | -64,000.00 |
| Sep 28, 2024 | -64,000.00 |
| Jun 29, 2024 | -77,000.00 |
| Jun 29, 2024 | -77,000.00 |
| Mar 30, 2024 | -1.00 Mn |
| Mar 30, 2024 | -1.00 Mn |
| Dec 31, 2023 | 10.92 Mn |
| Dec 31, 2023 | 10.92 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Jul 1, 2023 | 21.99 Mn |
| Jul 1, 2023 | 21.99 Mn |
| Apr 1, 2023 | -3.56 Mn |
| Apr 1, 2023 | -3.56 Mn |
| Dec 31, 2022 | -3.40 Mn |
| Dec 31, 2022 | -3.40 Mn |
| Oct 1, 2022 | -56.33 Mn |
| Oct 1, 2022 | -56.33 Mn |
| Jul 2, 2022 | -52.03 Mn |
| Jul 2, 2022 | -52.03 Mn |
| Apr 2, 2022 | -4.67 Mn |
| Apr 2, 2022 | -4.67 Mn |
| Dec 31, 2021 | -221.28 Mn |
| Dec 31, 2021 | -221.28 Mn |
| Oct 2, 2021 | -13.19 Mn |
| Oct 2, 2021 | -13.19 Mn |
| Jul 3, 2021 | -2.65 Mn |
| Jul 3, 2021 | -2.65 Mn |
| Apr 3, 2021 | -46.65 Mn |
| Apr 3, 2021 | -46.65 Mn |
| Dec 31, 2020 | -1.54 Mn |
| Dec 31, 2020 | -1.54 Mn |
| Sep 26, 2020 | -17.76 Mn |
| Sep 26, 2020 | -17.76 Mn |
| Jun 27, 2020 | -751,000.00 |
| Jun 27, 2020 | -751,000.00 |
| Mar 28, 2020 | -451,000.00 |
| Mar 28, 2020 | -451,000.00 |